Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

The potential use of stem cell-based therapies for the repair and regeneration of various
tissues and organs is a major goal in repair medicine. Stem cells are classified by their …

Photoaging is mainly induced by continuous exposure to sun light, causing multiple
unwanted skin characters and accelerating skin aging. Adipose-derived stem cells (ADSCs) …

Abstract Interleukin (IL)-10, a cytokine with anti-inflammatory effects, is produced by blood
cells and cells of various organs. Ischemia–reperfusion injury (IRI) is a systemic …

Mesenchymal stem cells constitute a pool of cells present throughout the lifetime in
numerous niches, characteristic of unlimited replication potential and the ability to …

Ischemia-reperfusion injury (I/RI), produced by an initial interruption of organ blood flow and
its subsequent restoration, contributes significantly to the pathophysiologies of stroke …

Significant progress has been made to advance stem cell products as potential therapies for
kidney diseases: various kinds of stem cells can restore renal function in preclinical models …

Pioglitazone (Pio), a peroxisome proliferators-activated receptor-γ (PPAR-γ) agonist, may
protect against renal ischemia/reperfusion injury (IRI). Recent studies have shown that …

The potential use of stem cell-based therapies for the repair and regeneration of various
tissues and organs offers a paradigm shift in regenerative medicine. The use of either …

Aims Hepatic ischemia-reperfusion (I/R) injury is an unavoidable complication of liver
surgery, often resulting in postoperative complications and liver dysfunction. Adipose …